Navigation Links
Thermo Fisher Scientific Reports Record Third Quarter Revenues and Adjusted EPS and Raises Full-Year Guidance
Date:10/25/2007

WALTHAM, Mass., Oct. 25 /PRNewswire-FirstCall/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, reported that revenues increased to a record $2.40 billion in the third quarter of 2007 (largely as a result of the November 2006 merger with Fisher Scientific), compared with $725 million in the 2006 quarter. GAAP diluted earnings per share (EPS) were $.49 in 2007, versus $.30 in the year-ago period, including a one-time favorable $.05 per share adjustment to the 2007 GAAP tax rate. GAAP operating income for the 2007 quarter was $254 million, compared with $75 million in 2006, and GAAP operating margin was 10.6%, compared with 10.4% a year ago.

Adjusted EPS grew 48% to $.65 in the third quarter of 2007, versus $.44 in the 2006 quarter. For a better year-to-year comparison of the company's operating performance, we are presenting our revenues and adjusted operating results on a pro forma basis, as if Thermo and Fisher had been combined for all of 2006. Third quarter revenues grew 7% over pro forma 2006 revenues of $2.24 billion. Currency translation increased revenues by 2% and there was no material effect from acquisitions, net of divestitures. Adjusted operating income for the quarter increased 17% over pro forma 2006 results, and adjusted operating margin expanded 150 basis points to 16.9%, compared with pro forma adjusted operating margin of 15.4% in the 2006 period. Adjusted EPS, adjusted operating income and adjusted operating margin are non-GAAP measures that exclude certain items detailed later in this press release under the heading "Use of Non-GAAP Financial Measures."

Third Quarter Highlights

-- Revenues grew 7% over pro forma 2006

-- Adjusted EPS rose 48%<
'/>"/>

SOURCE Thermo Fisher Scientific Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

Related biology technology :

1. Normalizing cDNA libraries using the EppendorfThermomixer
2. Rapid PCR* Using Active Tube Temperature Control On Thermos PCR Machines
3. A simple method to sequence from bacterial colonies using [a-33P] radiolabeled ddNTPs and Thermo Sequenase
4. Fisher Biosciences contracts with Madison-based GenTel BioSurfaces
5. UW-Madisons Beebe wins scientific award
6. Researchers say scientific reporting needs more perspective, less hype
7. Wisconsin stands at the center of scientific efforts to avert flu epidemics
8. Growth prompts new location for scientific instrument manufacturer
9. UW stem cell guru outlines scientific and political future
10. Wisconsin biotech sector featured in scientific magazine
11. Scientific Protein Laboratories Acquired by New York firm
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/1/2015)... May 1, 2015 According ... Market by Product (Equipment, Consumables), by Type (Monoclonal, Polyclonal), ... Labs, Research Institutes) - Analysis & Global Forecast ... the global Antibody Production Market for the forecast ... expected to reach $2.572 Billion by 2019 from ...
(Date:4/30/2015)... 2015 Spirax Sarco, the leader in ... to announce that for the first time in the ... of a Queen’s Award for Innovation – the UK’s ... manufacture of a unique flowmeter. , The Spirax Sarco ... traditional steam flow measurement. The device provides reliable, ...
(Date:4/30/2015)... , April 30, 2015   Tamir Biotechnology ... today an update on its Ebola antiviral therapy program. ... leading candidates, TMR004, is currently being evaluated and considered ... the battle against Ebola. During the first quarter of ... Leadership Meeting To Accelerate The Evaluation of Potential Treatments ...
(Date:4/30/2015)... /PRNewswire/ - BioAmber Inc. (NYSE: BIOA ), an ... has commenced an underwritten public offering of its common ... a 30-day option to purchase up to an additional ... in the public offering. The offering is subject to ... to whether or when the offering may be completed, ...
Breaking Biology Technology:Antibody Production Market worth $2.572 Billion by 2019 2Antibody Production Market worth $2.572 Billion by 2019 3Antibody Production Market worth $2.572 Billion by 2019 4Spirax Sarco Receives a Queen’s Award for Innovation 2Spirax Sarco Receives a Queen’s Award for Innovation 3Tamir Biotechnology Provides Update on TMR004 Development Against Mutating Ebola 2Tamir Biotechnology Provides Update on TMR004 Development Against Mutating Ebola 3Tamir Biotechnology Provides Update on TMR004 Development Against Mutating Ebola 4BioAmber Inc. Announces Public Offering Of Common Stock 2BioAmber Inc. Announces Public Offering Of Common Stock 3
... ... in Prima BioMed Ltd (ASX:PRR), an Australian Securities Exchange-listed oncology biotechnology company. KTA ... Investors, LLC on the transaction. A copy of Prima BioMed Ltd,s public announcement ... ...
... ... Dr. Rebecca Fitzgerald, known among her medical colleagues as the "Sculptra guru" here in the ... at this year,s 4 day SDEF Cosmetic Dermatology Seminar held in Santa Monica, Ca. ... Los Angeles, Ca (PRWEB) ...
... multiple times a day can be difficult for patients to ... 1 to 7 percent of the dose is actually absorbed ... PhD, director of the Laboratory for Biomaterials and Drug Delivery ... can gradually dispense a constant amount of medication to the ...
Cached Biology Technology:KTA Capital Advises SpringTree Global Investors on an AU$25.5 Million Investment in Prima BioMed Ltd 2Looking Older Than You Are May Have Little to Do With Wrinkles 2Looking Older Than You Are May Have Little to Do With Wrinkles 3A drug-dispensing contact lens 2
(Date:4/2/2015)... Sweden , April 2, 2015 ... for Q1 2015 attributed to somewhat higher than 125 ... in the year-end report 2014 that revenues for Q1 ... that the company reported for Q4 2014. The operating ... to be negative. The complete interim report will as ...
(Date:3/31/2015)... March 31, 2015   Guidepoint , a leading ... the Post-Surgical Pain Management TRACKER, part of the ... trends in the medical device and therapeutics markets. The ... including treatment volumes, market share, and adoption rates across ... with joint surgery. The Post-Surgical Pain Management ...
(Date:3/24/2015)... , March 24, 2015   NexID Biometrics ... with critical security-authentication needs, today announced the beginning of ... (FFD) solution. The company, based in ... at the three-day Connect:ID Expo, which began here today ... NexID said version 2.0 of its SDK boosts the ...
Breaking Biology News(10 mins):Fingerprint Cards Revises Revenues for Q1 2015 2Guidepoint Launches Post-Surgical Pain Management TRACKER 2Guidepoint Launches Post-Surgical Pain Management TRACKER 3NexID Begins Shipments Of Version 2.0 Fake-Finger-Detection Solution 2
... 2013 - BGI Health and ACIBADEM Healthcare Group ... Molecular Biology, signed a Memorandum of Understanding (MoU) ... to Turkey and improving Turkish reproductive healthcare. This ... technologies in the areas of Monogenic disorders, personalized ...
... do woolly mammoths wandering around the ancient spruce ... with predicting how species could respond to climate ... Center for Environmental Science,s Appalachian Laboratory, along with ... University of California-Merced, have received a three-year, $670,000 ...
... do nerve cells -- which can each be up to ... falling apart? Axons, the long, cable-like projections on neurons, ... molecular building block of the cell skeleton. The finding, which ... was reported in the April 10 issue of Neuron ...
Cached Biology News:BGI Health forms partnership with ACIBADEM hospital on genetic disease testing 2Scientists look to ancient past to better predict how species may respond climate change 2Scientists learn what makes nerve cells so strong 2
Laminin beta-1/gamma-1 (612C10)...
HSV 1 IgM...
100 ug affinity purified rabbit anti-JIP-1 polyclonal antibody. Reacts with mouse and rat. Perform well in Western blotting. Other applications have not been tested. Storage Temperature: -20C Shi...
Epstein-Barr Virus (EBV) (EBNA-1)...
Biology Products: